Tender joint count may not reflect inflammatory activity in established rheumatoid arthritis patients - results from a longitudinal study.
Tender joint count (TJC) is included in Composite Disease Activity Scores (CDAS) (DAS28/CDAI/SDAI). The impact of having predominantly tender joints was explored by use of the Tender-Swollen Joint count Difference (TSJD). Ultrasound (US) provides a measure of joint inflammation. The present study aimed to explore the cross-sectional and longitudinal associations between TSJD and a spectrum of outcome measures including US scores in patients with established rheumatoid arthritis (RA) during follow-up on bDMARD treatment. This is an observational study of 209 patients with established RA consecutively included when initiating bDMARD and followed with clinical, laboratory and comprehensive US examinations at 0, 1, 2, 3, 6 and 12 months. Patients were categorized into two groups - with predominantly tender (TSJD>0) or predominantly swollen (TSJD≤0) joints. Statistical analyses included Pearson's correlation, independent samples T-test and regression analyses. TJC had high correlations only with patient reported outcomes (PROMs)(p<0.001). Levels of CDAS and PROMs were significantly higher (p<0.001) at all visits in patients with TSJD>0 compared to TSJD<0, laboratory markers and assessor's global were similar, and US sum scores were significantly lower (p<0.001-0.03). Baseline TSJD positively predicted levels of all CDAS at 6 months (p<0.001-0.019) but was a negative predictor of US sum scores (grey scale and power Doppler) at 6 and 12 months (p<0.001). Patients with predominantly tender joints had higher CDAS but lower levels of inflammation defined by US. These findings indicate that inclusion of TJC in CDAS may contribute to misleading information about inflammatory activity. This article is protected by copyright. All rights reserved.